A T-cell stimulatory protein and interleukin-10 synergize to prevent gut inflammation
FDA panel rejects Pfizer’s arthritis drug as too risky
25 March 2021New genetic clues point to new treatments for ‘silent’ stroke
25 March 2021A T-cell stimulatory protein and interleukin-10 synergize to prevent gut inflammation
Researchers have found an unexpected synergy between a T-cell stimulatory protein—the ICOS ligand—and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice. The study will aid the understanding of, and future research into, this immune disorder, which includes Crohn’s disease and ulcerative colitis. About 1.6 million Americans have inflammatory bowel disease.
